Development and validation of a highly sensitive urine-based test to identify patients with colonic adenomatous polyps

Clinical and Translational Gastroenterology

Volumn 5, Issue , 2014, Pages

  Wang, Haili ^a   Tso, Victor ^a   Wong, Clarence ^a   Sadowski, Dan ^a   Fedorak, Richard N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; BIOTECHNOLOGY; CANADA; COLON ADENOMA; COLON CANCER; COLON POLYP; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FECES ANALYSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLISM; METABOLITE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; URINALYSIS; VALIDATION STUDY; AGE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLON POLYPOSIS; COLORECTAL CANCER; CONCENTRATION RESPONSE; FAMILY HISTORY; NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; SMOKING HABIT; STANDARD;

2 OXOGLUTARIC ACID; 3 HYDROXYBUTYRIC ACID; 3 HYDROXYMANDELATE; 3 HYDROXYPHENYLACETATE; ACETONE; ADIPIC ACID; ALCOHOL; ASPARAGINE; BENZOIC ACID; BETA ALANINE; BUTYRIC ACID; HISTIDINE; HISTIDINE DERIVATIVE; MANDELIC ACID; METHANOL; SERINE; TRIGONELLINE; TYROSINE; UNCLASSIFIED DRUG;

EID: 84898885414     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2014.2     Document Type: Article

References (36)

1. Arthur JC, Jobin C. The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis 2011; 17: 396-409.
2. Castellarin M, Warren RL, Freeman JD et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306.
3. Kostic AD, Gevers D, Pedamallu CS et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-298.
4. Shen XJ, Rawls JF, Randall T et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010; 1: 138-147.
5. Pagnini C, Corleto VD, Mangoni ML et al. Alteration of local microflora and alpha-definsins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol 2011; 45: 602-610.
6. Claudino WM, Quattrone A, Biganzoli L et al. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 2007; 25: 2840-2846.
7. Patel NR, McPhail MJ, Shariff MI et al. Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology. Expert Rev Gastroenterol Hepatol 2012; 6: 239-251.
8. Yoshie T, Nishiumi S, Izumi Y et al. Regulation of the metabolite profile by an APC gene mutation in colorectal cancer. Cancer Sci 2012; 103: 1010-1021.
9. Wang H, Tso VK, Slupsky CM et al. Metabolomics and detection of colorectal cancer in humans: a systematic review. Future Oncol 2011; 6: 1395-1406.
10. Cheng Y, Xie G, Chen T et al. Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res 2012; 11: 1354-1363.
11. Ma Y, Zhang P, Wang F et al. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer. Ann Surg 2012; 255: 720-730.
12. Mal M, Koh PK, Cheah PY et al. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry. Anal Bioanal Chem 2012; 403: 483-493.
13. Nishiumi S, Kobayashi T, Ikeda A et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One 2012; 7: e40459.
14. Wang W, Feng B, Li X et al. Urinary metabolic profiling of colorectal carcinoma based on online affinity solid phase extraction-high performance liquid chromatography and ultra performance liquid chromatography-mass spectrometry. Mol Biosyst 2010; 6: 1947-1955.
15. Wong CK, Fedorak RN, Prosser CI et al. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Int J Colorectal Dis 2012; 27: 1657-1664.
16. Burch JA, Soares-Weiser K St, John DJ et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 2007; 14: 132-137.
17. Birkenfeld S, Belfer RG, Chared M et al. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. J Med Screen 2011; 18: 135-141.
18. Cani PD, Delzenne NM, Amar J et al. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) 2008; 56: 305-309.
19. Takaishi H, Matsuki T, Nakazawa A et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 2008; 298: 463-472.
20. McMillan L, Butcher SK, Pongracz J et al. Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases. Br J Cancer 2003; 88: 748-753.
21. Segain JP, de la Bletiere DR, Bourreille A et al. Butyrate inhibits inflammatory responses through NF kappa B inhibition: implications for Crohn's disease. Gut 2000; 47: 397-403.
22. Finnie IA, Dwarakanath AD, Taylor BA et al. Colonic mucin synthesis is increased by soidum-butyrate. Gut 1995; 36: 93-99.
23. Cherbut C. Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 2003; 62: 95-99.
24. Rosignoli P, Fabiani R, De Bartolomeo A et al. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 2001; 22: 1675-1680.
25. Hague A, Manning AM, Hanlon KA et al. Sodium-butyrate induces apoptosis in human colonic tumor-cell lines in a p53-independent pathway-implications for the possible role of dietary fiber in the prevention of large-bowel cancer. Int J Cancer 1993; 55: 498-505.
26. Freeman HJ. Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestinal neoplasia. Gastroenterology 1986; 91: 596-602.
27. Zoran DL, Turner ND, Taddeo SS et al. Wheat bran reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. J Nutr 1997; 127: 2217-2225.
28. Bajou K, Noel A, Gerard RD et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 1998; 4: 923-928.
29. Bajou K, Peng H, Laug WE et al. Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell 2008; 14: 324-334.
30. Liu GH, Shuman MA, Cohen RL. Coexpression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung-cancer cells. Int J Cancer 1995; 60: 501-506.
31. Buchholz M, Biebl A, Neessbe A et al. SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. Cancer Res 2003; 63: 4945-4951.
32. Candia BJ, Hines WC, Heaphy CM et al. Protease nexin-1 expression is altered in human breast cancer. Cancer Cell Int 2006; 6: 16.
33. Yang SF, Dong QG, Yao M et al. Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by Tc-99m-MDP bone scintigraphy. Nucl Med Biol 2009; 36: 313-321.
34. Kyoto Encyclopedia of Genes and Genomes (KEGG) 2011. Accessed November 2010 to January 2011; Available from http://www.genome.jp/kegg/.
35. Son DO, Satsu H, Kiso Y et al. Characterization of carosine uptake and its physiological function in human intestinal epithelial Caco-2 cells. Biofactors 2004; 21: 395-398.
36. Wang H, Gies N, Tso VK et al. The highly accurate urine metabolomics diagnostic test for colonic adenoma reverts to normal following adenoma removal-abstract. Gastroenterology 2012; 142: S-771.